Improving the success rate of clinical application of drug discovery seeds through the development of novel medical devices and their deployment to disease models

The aim of this division is to develop novel, advanced medical devices, and tests them with disease models to improve the success rate of clinical evaluation of therapeutic drug seeds. Using ultra-early diagnosis and drug efficacy evaluation technology with quantum (hyperpolarized) MRI and clinical diagnostic imaging equipment such as endoscopes, we seek to develop a system to better evaluate safety and efficacy of drug discovery seeds in disease models to shorten evaluation periods and accelerate development and improve the success rate.